Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14278288 | 0.89 | MEN1 (0.39) | RAB9ANPC1MEN1KMT2AALDH1A1 | |
| SCHEMBL14278286 | 0.87 | RAB9A (0.46) | RAB9ANPC1MEN1KMT2AHTT | |
| SCHEMBL14364309 | 0.86 | CA1 (0.41) | MEN1KMT2AALDH1A1 | |
| SCHEMBL14364313 | 0.86 | ALDH1A1 (0.36) | MEN1KMT2AALDH1A1 | |
| SCHEMBL14364330 | 0.84 | BRS3 (0.39) | MEN1KMT2AALDH1A1 | |
| SCHEMBL14307938 | 0.81 | CFTR (0.37) | MEN1KMT2AALDH1A1 | |
| SCHEMBL14364362 | 0.80 | ALDH1A1 (0.45) | HTTALDH1A1 | |
| SCHEMBL14364312 | 0.80 | CNR2 (0.31) | MEN1KMT2AALDH1A1 | |
| SCHEMBL14364359 | 0.80 | KMT2A (0.42) | RAB9ANPC1MEN1KMT2AALDH1A1 | |
| SCHEMBL14364314 | 0.78 | P2RX4 (0.32) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070265281-A1 | Organic Compounds and Their Uses | COTTENS SYLVAIN | 2007-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265281-A1 | Organic Compounds and Their Uses | OAT, OTC, AOX1 | RAB9A 4474/4885NPC1 177/4885MEN1 2302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.